Regulatory labeling manager overseeing global IMP labeling for Telix’s precision radiopharmaceuticals. Supporting clinical trials and regulatory compliance for cancer and rare-disease treatments.
Responsibilities
Lead the creation, revision, review, agreement, and maintenance of Investigational Medicinal Product (IMP) and Calibration Labeling
Collaborate with Regulatory Affairs, Clinical Operations, Quality, Contract Research Organizations, Contract Manufacturing Organizations, translation vendors, artwork vendors, and packaging vendors
Ensure compliance with local and regional regulations and internal policies across the United States, European Union, United Kingdom, Australia, Canada, Asia-Pacific, and other participating countries
Provide labeling expertise during protocol development, clinical study start-up, amendments, and country expansion
Coordinate translation activities and verification of multilingual labeling content
Coordinate artwork review and approval in the compliance system
Manage version control and change management for IMP documentation
Support IMP labeling submissions or notifications where required
Evaluate new regulatory requirements and industry trends and assess impacts on studies
Support regulatory inspections and audits with IMP documentation and subject matter expertise
Serve as regulatory point of contact for IMP labeling, independently resolving issues and escalating complex matters
Maintain efficient labeling processes using standardized templates, checklists, and workflows
Identify process improvements, best practices, and tools
Assist with other clinical or commercial labeling activities and special projects
Requirements
Bachelor's degree in life sciences
Minimum 5 years’ experience in pharmaceutical regulatory affairs, global labeling, clinical, or clinical operations, including at least 2 year of experience in Investigational Medicinal Product (IMP) labeling (“Clinical Labeling”)
Experience supporting IMP (clinical) labeling for clinical trials across multiple regions and regulatory jurisdictions
Knowledge of IMP lifecycle management
In-depth understanding of relevant international, national, and regional regulatory and/or clinical frameworks, processes, and requirements
Strong understanding of GMP, GCP, EU CTR, Annex VI, Annex 13, and FDA IMP requirements
Proficiency with Microsoft Office applications and labeling management systems
Working knowledge of Veeva is desired
Strong communication, collaboration, adaptability, resilience, and continuous-learning capabilities
Sun Life compliance director overseeing CIRO trade supervision and risk - based monitoring across mutual fund and securities businesses. Leading regulatory oversight, transformation, reporting, and a high - performing compliance team.
Compliance Manager advising Affirm’s consumer card program on U.S. financial regulations. Reviewing card products, marketing, disputes, and remediation for compliant growth.
Compliance Manager owning risk - based advisory for Affirm Card at Affirm, which provides transparent pay - over - time financial products. Reviewing card compliance, remediation, and regulatory requirements.
Sun Life AVP leading strategic programs, innovation, insights and regulatory operations. Integrating governance, modernization, analytics and change across Canadian wealth and insurance businesses.
Quality and compliance specialist overseeing GMP, accreditation, QMS and pharmacovigilance for Shared Health Diagnostic Services in Manitoba. Ensuring regulatory compliance across provincial healthcare sites.
Compliance officer investigating energy - sector violations for British Columbia’s energy regulator. Conducting inspections, enforcement actions, emergency response, and administrative case preparation.
Senior Compliance Consultant strengthening Sun Life’s Canadian disability - management governance and risk controls. Leading audits, risk validation, business continuity, and compliance initiatives for Group Disability.
Regulatory intelligence leader monitoring global rules for Telix Pharmaceuticals, a precision radiopharmaceutical company. Translating regulatory developments into strategies, communications, and cross - functional actions.